Correlation Between ATyr Pharma and Trevi Therapeutics
Can any of the company-specific risk be diversified away by investing in both ATyr Pharma and Trevi Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ATyr Pharma and Trevi Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ATyr Pharma and Trevi Therapeutics, you can compare the effects of market volatilities on ATyr Pharma and Trevi Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ATyr Pharma with a short position of Trevi Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ATyr Pharma and Trevi Therapeutics.
Diversification Opportunities for ATyr Pharma and Trevi Therapeutics
0.23 | Correlation Coefficient |
Modest diversification
The 3 months correlation between ATyr and Trevi is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding ATyr Pharma and Trevi Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Trevi Therapeutics and ATyr Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ATyr Pharma are associated (or correlated) with Trevi Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Trevi Therapeutics has no effect on the direction of ATyr Pharma i.e., ATyr Pharma and Trevi Therapeutics go up and down completely randomly.
Pair Corralation between ATyr Pharma and Trevi Therapeutics
If you would invest 295.00 in Trevi Therapeutics on September 4, 2024 and sell it today you would lose (9.00) from holding Trevi Therapeutics or give up 3.05% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 0.0% |
Values | Daily Returns |
ATyr Pharma vs. Trevi Therapeutics
Performance |
Timeline |
ATyr Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Trevi Therapeutics |
ATyr Pharma and Trevi Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ATyr Pharma and Trevi Therapeutics
The main advantage of trading using opposite ATyr Pharma and Trevi Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ATyr Pharma position performs unexpectedly, Trevi Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Trevi Therapeutics will offset losses from the drop in Trevi Therapeutics' long position.ATyr Pharma vs. Mereo BioPharma Group | ATyr Pharma vs. Terns Pharmaceuticals | ATyr Pharma vs. PDS Biotechnology Corp | ATyr Pharma vs. Inozyme Pharma |
Trevi Therapeutics vs. Cue Biopharma | Trevi Therapeutics vs. AN2 Therapeutics | Trevi Therapeutics vs. Bioatla | Trevi Therapeutics vs. Spero Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |